Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -9 of 9
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
4/29/2008
 
First Published:
2/21/2003
1.
Phase III Randomized Study of Ultraviolet A Light Therapy With Methoxsalen (PUVA) With or Without Bexarotene in Patients With Mycosis Fungoides
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Over 18
Other
EORTC-21011
NCT00056056
Last Modified:
6/22/2007
 
First Published:
11/10/2005
2.
Phase II Study of Doxorubicin HCl Liposome Followed By Bexarotene in Patients With Stage IB-IV Cutaneous T-Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
MSKCC-05098
NCT00255801
Last Modified:
5/22/2008
 
First Published:
1/16/2007
3.
Phase II Study of Bexarotene and Sargramostim (GM-CSF) in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
JHOC-J0675
JHOC-NA_00003076, NCT00425477
4.
BATTLE Program: Tarceva and Targretin in Patients With NSCLC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
2005-0826
NCT00411632
Last Modified:
10/7/2008
 
First Published:
8/3/2007
5.
Phase II Study of Bexarotene and Tretinoin With Combination Chemotherapy Comprising Cisplatin or Carboplatin, Docetaxel, and Capecitabine in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
EISAI-2007-01-22
2007-01-22, NCT00514293
6.
Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
UPCC 04407
UPCC 04407, NCT00615784
First Published:
4/15/2008
7.
Phase II Study of Gemcitabine Hydrochloride and Bexarotene in Patients With Progressive or Refractory Stage IB-IVA Cutaneous T-cell Non-Hodgkin Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
CRUK-UCL-GEMBEX
CRUK-UCL GemBex, EU-20841, EUDRACT 2006-000591-33, NCT00660231
8.
Study of Tarceva and Targretin in Stage I-II Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
Other
D-0453
NCT00125372
9.
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
Other
COMIRB# 07-0727
NCT00718770
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute